Venture funding for life science companies plummets in Q2, says report
This article was originally published in Scrip
Executive Summary
US venture capital investment in life science companies declined for the fourth quarter in a row – a predictable drop considering the limitations on exit strategies – plunging 39% on a year-over-year basis during the second quarter of 2012 while VC dollars across all industries fell just 12% in the same timeframe.